Intravitreal (IVT) Injectables Market is poised to value over USD 20 billion by 2029 end at a CAGR of over 6% during the forecast period 2021 to 2029.

Intravitreal injection involves injecting a fine needle into the eye to inject drugs into the eyeball. These drugs will then be applied directly to the vitreous humor. There are some eye diseases that can be treated with this drug, such as age-related macular degeneration (AMD), diabetic retinopathy, and infections inside the eye like endophthalmitis. Compared to topical administration, this method allows for more targeted delivery of medications because the needle can pass directly through the anatomical barrier (e.g. cornea, conjunctiva, and lens) and dynamic barrier (e.g. tears and aqueous humor). It could also minimize adverse drug effects to other body tissues via systemic circulation, which could be a risk from an intravenous injection of medications. It is possible for infections or other complications to occur during injections, but with the appropriate precautions throughout the process, the chances for these complications to occur can be reduced.

Vitreo-retinal disease is a leading cause of blindness and vision impairment across the world. Retinal problems affect millions of individuals worldwide, frequently resulting in vision loss or blindness. Age-related macular degeneration, diabetic macular edoema, diabetic retinopathy, and other retinal degenerative illnesses are frequent.

More than 70 million people suffer from age-related macular degeneration, according to the most recent numbers acquired throughout the study. Intravitreal (IVT) injectables are an important part of the therapy of retinal diseases. Patients with chronic retinal illnesses frequently require many doses of intravitreal (IVT) injectables, hence the intravitreal (IVT) injectables market is expected to increase rapidly over the projected period.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Intravitreal (IVT) Injectables Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Intravitreal (IVT) Injectables Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Intravitreal (IVT) Injectables Market:
• Alcon Pharmaceuticals
• Novartis  
• Regeneron Pharmaceuticals Inc.
• Allergan
• Alimera Sciences
• Bristol Myers Squibb
• Bausch & Lomb
• F. Hoffmann-La Roche
• Thrombogenics 
• Valeant Pharmaceuticals International
(Note: The list of the major players will be updated with the latest market scenario and trends)

Intravitreal (IVT) Injectables Market Segmentation:
By Drug Class
• Anti-VEGF
• Antibiotics
• Corticosteroids
• Antifungals
• Antivirals

By Indication 
• Diabetic Retinopathy
• Macular Degeneration
• Endophthalmitis
• Retinal Vein Occlusions

By Distribution Channel 
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Intravitreal (IVT) Injectables Market Sample:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Intravitreal (IVT) Injectables Market By Drug Class, By Indication, By Distribution Channel and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Targeted Antigen launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics